Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy
ClinicoEconomics and Outcomes Research · 2026-06 · Volume 18 · 1-14
DOI: 10.2147/ceor.s599644 ↗Kurz gefasst
Fachartikel in der Zeitschrift ClinicoEconomics and Outcomes Research, 2026-06. Verfasst von Gianni Ghetti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Economics and Outcomes Research, AdRes, Turin, Italy. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Economics and Outcomes Research, AdRes, Turin, Italy.
- Department of Value & Access, Amgen Italy srl, Milan, Italy.
- Department of Medical Affairs, Amgen Italy srl, Milan, Italy.
- Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy.
ORCID-Profile: Gianni Ghetti
Zitieren
APA
Ghetti, G., Castello, L., Odonde, L. A., De Fazio, S., Stella, A., Bruno, A., Marchionne, E., & Bonifacio, M. (2026). Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy. ClinicoEconomics and Outcomes Research, Volume 18, 1-14. https://doi.org/10.2147/ceor.s599644
Vancouver
Ghetti G, Castello L, Odonde LA, De Fazio S, Stella A, Bruno A, et al. Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy. ClinicoEconomics and Outcomes Research. 2026;Volume 18:1-14. doi:10.2147/ceor.s599644
BibTeX
@article{Ghetti2026,
author = {Ghetti, Gianni and Castello, Luca and Odonde, Linet Awino and De Fazio, Serena and Stella, Andrea and Bruno, Angela and Marchionne, Emanuele and Bonifacio, Massimiliano},
title = {Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy},
journal = {ClinicoEconomics and Outcomes Research},
year = {2026},
volume = {Volume 18},
pages = {1--14},
doi = {10.2147/ceor.s599644}
}
EUVIMED